Gastrointestinal Disorders and Toxicities Induced By Anticancer Drugs. Another Risk Factor of Bleeding in Cancer-Associated Thrombosis

被引：1
|
作者：
Janus, Nicolas
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141814
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 14 条
  • [1] Is Anaemia Another Bleeding Risk in Cancer-Associated-Thrombosis?
    Janus, Nicolas
    BLOOD, 2020, 136
  • [2] Cancer-Associated Thrombosis and Bleeding Risk in Gastrointestinal Malignancies with Apixaban and Rivaroxaban Compared to Low Molecular Weight Heparin
    Houghton, Damon E.
    Bott-Kitslaar, Dalene M.
    Vargas, Emily
    Hodge, David O.
    Lang, Teresa R.
    Peterson, Lisa
    Casanegra, Ana I.
    McBane, Robert D.
    Wysokinski, Waldemar E.
    Froehling, David A.
    BLOOD, 2018, 132
  • [3] Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued
    Mayenga, Marie
    Falvo, Nicolas
    Mahe, Isabelle
    Jannot, Anne-Sophie
    Gazeau, Benoit
    Meyer, Guy
    Gendron, Nicolas
    Sanchez, Olivier
    Djennaoui, Sadji
    Planquette, Benjamin
    CANCERS, 2023, 15 (15)
  • [4] In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients
    Poenou, Geraldine
    Toledano, Emmanuel
    Helfer, Helene
    Plaisance, Ludovic
    Happe, Florent
    Versini, Edouard
    Diab, Nevine
    Djennaoui, Sadji
    Mahe, Isabelle
    CANCERS, 2022, 14 (08)
  • [5] Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis
    Frere, Corinne
    Font, Carme
    Esposito, Francis
    Crichi, Benjamin
    Girard, Philippe
    Janus, Nicolas
    SUPPORTIVE CARE IN CANCER, 2022, 30 (04) : 2919 - 2931
  • [6] Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis
    Corinne Frere
    Carme Font
    Francis Esposito
    Benjamin Crichi
    Philippe Girard
    Nicolas Janus
    Supportive Care in Cancer, 2022, 30 : 2919 - 2931
  • [7] Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score
    de Winter, Maria A.
    Dorresteijn, Jannick A. N.
    Ageno, Walter
    Ay, Cihan
    Beyer-Westendorf, Jan
    Coppens, Michiel
    Klok, Frederikus A.
    Moustafa, Fares
    Riva, Nicoletta
    Ruiz Artacho, Pedro C.
    Vanassche, Thomas
    Nijkeuter, Mathilde
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (05) : 818 - 829
  • [8] Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?
    Xu, Ke
    Chan, Noel C. C.
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (05) : 487 - 489
  • [9] CA19-9-Positive Extracellular Vesicle Is a Risk Factor for Cancer-Associated Thrombosis in Pancreatic Cancer
    Shibata, Chikako
    Otsuka, Motoyuki
    Ishigaki, Kazunaga
    Seimiya, Takahiro
    Kishikawa, Takahiro
    Fujishiro, Mitsuhiro
    GASTRO HEP ADVANCES, 2024, 3 (04): : 551 - 561
  • [10] Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review
    Bucciol, Regan
    Othman, Maha
    CURRENT OPINION IN HEMATOLOGY, 2023, 30 (05) : 180 - 185
12